The speakers (in the middle) gather with the AstraZeneca team (at the left) and Diabeaters Club members (at the right) at the call-to-action activity.AstraZeneca, together with local diabetes patient group The Diabeaters Club, conducted a media briefing to elaborate further on these risks in line with World Diabetes Day. The event, titled ‘Diabetescussion: Chronicles of the Heart and More’, was held at the EDSA Shangri-la Hotel last November 29, 2018.
Dr. Wilson Carbonell, AstraZeneca Senior Medical Affairs Manager, served as the host. The first speaker, Dr. Ariel Miranda, Director of Cardinal Santos Cardiovascular Institute and Cardiac Catheterization Laboratories, emphasized the relationship of cardiovascular diseases to the burden of Type-2 Diabetes. “Heart failure is an early complication of type 2 diabetes. Around 888,000 Filipino diabetics have heart failure. Heart failure accounts for 9% of total hospitalizations in the country, which puts a heavy financial burden on patients and their family. Moreover, around one million Filipinos suffer from diabetes and chronic kidney disease,” he said.
To effectively control blood sugar without increasing the already elevated risk of cardiovascular disease, Dr. Rosa Allyn Sy introduced the use of SGLT2 inhibitors.
Dapagliflozin, the SGLT2 inhibitor developed by AstraZeneca, was used in the DECLARE trial that Dr. Luc Van Gaal talked about. The Professor of Medicine, Department of Endocrinology, Metabolism & Clinical Nutrition, Faculty of Medicine at Antwerp University Hospital in Belgium, shared the results of the study that evaluated the cardiovascular safety and efficacy of Dapagliflozin. “The landmark DECLARE trial showed that Dapagliflozin significantly reduced the risk of hospitalization for heart failure and death due to cardiovascular causes in a broad range of patient with type 2 diabetes, as well as provides heart and kidney protection,” he said. Aside from its intended purpose, this diabetes medication also helps in weight management.
Singer, comedienne, and entertainer Marissa Sanchez was present to share her experience living with T2D, which she fondly called as ‘cancer of the blood sugar’. Some members of the Diabeaters Club also shared their stories.
Moderating the open forum was Dr. Nemencio Nicodemus Jr., Professor at the University of the Philippines – College of Medicine, Department of Biochemistry and Molecular Biology. After the event, healthcare professionals went around each table to give attendees diet education, exercise tips, and diabetes statistics in the country.